Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients

<div>(a) Identification of best cutoff of cluster. (b) The distribution of each cluster by PCA method in factoextra package. (c) Survival analysis of TCGA-PDAC by clusters. (d) Identification of the value of grouping by silhouette width plots. (e) Visualization of each cluster using the NMF method.</div>

Journal of Oncology

fig3

Figure 3

Figure 3: Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 

Figure 3 | Identification and Validation of Three PDAC Subtypes and Individualized GSVA Immune Pathway-Related Prognostic Risk Score Formula in Pancreatic Ductal Adenocarcinoma Patients 